Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity
- 27 February 2007
- journal article
- research article
- Published by Wiley in Cytometry Part B: Clinical Cytometry
- Vol. 72B (4) , 265-275
Abstract
Background: In this study, we evaluated alternative possibility for CFSE beryllium flow cytometric test against beryllium blood lymphocyte proliferation test (BeLPT) as a standard radioactive clinical screening method to identify sensitization to beryllium.Methods: Delta PD (the ratio of divided cell population to the total number of cells with subtracted counts of unstimulated cells) of specific beryllium‐induced pathogenic CD3+CD4+ T‐lymphocytes and stimulation index (SI) in CFSE proliferation test was compared with delta counts per minute (mean test CPM minus mean control CPM) and SI in radioactive blood BeLPT.Results: Comparison analysis of CFSE and BeLPT demonstrated excellent agreement between delta PD and delta CPM (κ = 0.845, P << 0.0001). We determined 6.8% positive subjects in the beryllium‐exposed, Be‐LPT‐negative group. The decreased mean difference of these indexes to percentage of average and the long tail in the plot reflects increased sensitivity. CFSE/CD4+ T‐cell proliferation assay has 100% specificity, significantly higher sensitivity and efficiency than BeLPT.Conclusions: Both delta PD, measured by the precursor frequencies method in CFSE assay and delta CPM, defined by tritiated thymidine in BeLPT, can be used for the enumeration of beryllium specific CD4+ T‐cell proliferation and may substantially improve the quality of the early diagnosis of beryllium hypersensitivity. © 2007 Clinical Cytometry Society.Keywords
This publication has 41 references indexed in Scilit:
- Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative responseJournal of Clinical Investigation, 2005
- Flow cytometric test for beryllium sensitivityCytometry Part B: Clinical Cytometry, 2004
- Clinical Application of Beryllium Lymphocyte Proliferation TestingClinical and Vaccine Immunology, 2003
- Racial differences in prevalence of a supratypic HLA‐genetic marker immaterial to pre‐employment testing for susceptibility to chronic beryllium diseaseAmerican Journal of Industrial Medicine, 2002
- Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate β69Human Immunology, 2001
- Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response.Journal of Clinical Investigation, 1997
- Chronic Beryllium Disease—From the Workplace to Cellular Immunology, Molecular Immunogenetics, and BackClinical Immunology and Immunopathology, 1994
- Blood Cell Proliferation Response to Beryllium: Analysis by Receiver-Operating CharacteristicsJournal of Occupational and Environmental Medicine, 1991
- Screening Blood Test Identifies Subclinical Beryllium DiseaseJournal of Occupational and Environmental Medicine, 1989
- Maintenance of Alveolitis in Patients with Chronic Beryllium Disease by Beryllium-Specific Helper T CellsNew England Journal of Medicine, 1989